Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001104659-23-001881

10% owner bought 180,703 shares at an average $7.28 ($1,314,806)

From the SEC's structured data for this filing

Trades in this filing

RA CAPITAL MANAGEMENT, L.P. · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-04 Purchase : show line 1 in the form +122,334 $7.03 $859,714 9,628,259 I
2023-01-04 Purchase : show line 2 in the form +58,369 $7.80 $455,091 9,686,628 I
Open-market purchases · 180,703 sh · avg $7.28 · $1,314,806
Loading xslF345X03/tm232548-1_4seq1.xml…